Cancer Research UK and Merck KGaA to co-develop leukaemia candidate
January 4, 2010Research and Development Merck Serono, leukaemia, oncology
Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …
New approaches in lung cancer
January 1, 2010Sales and Marketing lung cancer
Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …
Celgene
January 1, 2010Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide
Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Patient involvement must improve, says European regulator
December 31, 2009Sales and Marketing EMEA, patients
The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …
Rebecca Lim to head up WorldEvents’ Asian expansion
December 24, 2009Business Services Rebecca Lim, WorldEvents, appointment, business services
Rebecca Lim has been appointed by WorldEvents to lead its new Hong Kong office. She is an event professional with …
Promising new drugs could bypass UK approval process
December 23, 2009Sales and Marketing MHRA, MISG, hta, market access
UK patients could next year be given access to drugs that are still in the later stages of clinical development, …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
PDS appoints Paul Butler and Martin Slade
December 22, 2009Manufacturing and Production PDS, Pharmaceutical Development Services, appointment, manufacturing and production
Pharmaceutical Development Services Ltd (PDS) has expanded its API (Active Pharmaceutical Ingredient) auditing capability, appointing two new associates. Paul Butler …
US health reform heads for decisive vote
December 22, 2009Sales and Marketing Obama, Senate, US healthcare
The US Senate has passed new healthcare legislation, giving President Barack Obama signs of progress on reform in both parliamentary …
Contract research news in brief
December 22, 2009Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG
Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
Sanofi pulls out of Dagenham
December 21, 2009Manufacturing and Production Essex, Sanofi, closure
The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …
Sanofi’s Plavix combination recommended for European approval
December 21, 2009Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux
Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
Digital Pharma: Roche tackles sidewiki
December 21, 2009Medical Communications Roche, digi, digital pharma, google, sidewiki
Roche has become the second pharma company to tackle sidewiki on its corporate website, posting an entry that sets out …
Dr Michael Rosenblatt appointed chief medical officer Merck
December 21, 2009Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing
Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Merck buys Avecia to boost biomanufacturing
December 21, 2009Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm
Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
Time-sensitive shipments go further
December 18, 2009Manufacturing and Production
The logistical challenges of transporting clinical trials samples over long distances arerapidly being overcome, says Sue Lee, Manager of Biopharm …
Chiltern Announces Collaboration with Dr Nawab Qizilbash
December 18, 2009Research and Development
Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
Boehringer’s ovarian cancer drug enters phase III
December 18, 2009Research and Development, Sales and Marketing Boehringer, Cancer, ovarian
Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
UK supports stem cell research with online toolkit
December 18, 2009Research and Development ReNeuron, regenerative medicine, stell cell
A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
